NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
6.07
-0.95 (-13.53%)
At close: May 27, 2026, 4:00 PM EDT
6.31
+0.24 (3.95%)
After-hours: May 27, 2026, 6:52 PM EDT

NextCure Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2250223239166
Market Cap Growth
75.04%130.42%-32.13%-18.77%-76.42%-44.73%
Enterprise Value
-4.2212.07-41.88-70.54-114.14-53.51
Last Close Price
6.0714.199.2513.6816.9272.00
PB Ratio
0.950.110.050.070.090.40
P/TBV Ratio
0.810.090.050.070.090.39
EV/EBITDA Ratio
--0.741.101.590.80
EV/EBIT Ratio
--0.701.041.500.76
EV/FCF Ratio
--1.011.312.040.90
Debt / Equity Ratio
0.150.010.010.010.020
Net Debt / Equity Ratio
-0.97-0.08-0.14-0.23-0.36-0.52
Net Debt / EBITDA Ratio
0.480.681.121.602.143.30
Net Debt / FCF Ratio
0.520.761.541.902.743.68
Quick Ratio
4.323.967.1715.7317.5233.23
Current Ratio
4.614.147.5016.3817.9734.48
Return on Equity (ROE)
-21.97%-12.19%-12.58%-14.45%-17.59%-16.68%
Return on Assets (ROA)
-127.27%-87.93%-57.20%-43.33%-35.59%-25.78%
Return on Invested Capital (ROIC)
13076.70%-24834.50%-769.90%-483.48%-484.89%-458.69%
Return on Capital Employed (ROCE)
-158.69%-103.90%-62.09%-45.67%-36.96%-26.60%
Buyback Yield / Dilution
-53.00%-21.97%-0.46%-0.33%-0.46%-0.30%
Total Shareholder Return
-53.00%-21.97%-0.46%-0.33%-0.46%-0.30%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q